J. Goldman & Co’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-58,788
Closed -$731K 468
2022
Q4
$731K Buy
+58,788
New +$750K 0.04% 251

Other funds holding SBRA

J. Goldman & Co's SBRA Position: Q1 2023 in Review

J. Goldman & Co sold out of Sabra Healthcare REIT (SBRA) in Q1 2023, closing a stake of 58,788 shares — an estimated $731K sold.

J. Goldman & Co first reported a position in SBRA in Q4 2022 and held it in 1 quarter. The position peaked at $731K in Q4 2022. 324 funds tracked by Wall St. Rank hold SBRA as of Q1 2023.

  • J. Goldman & Co reported no remaining Sabra Healthcare REIT position as of Q1 2023 after selling out during the quarter.
  • J. Goldman & Co sold 58,788 Sabra Healthcare REIT shares in Q1 2023, an estimated $731K.
  • J. Goldman & Co first reported a position in Sabra Healthcare REIT in Q4 2022 and held it in 1 quarter.
  • J. Goldman & Co's Sabra Healthcare REIT position peaked at $731K in Q4 2022.
  • 324 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2023.

Based on J. Goldman & Co's 13F filing for Q1 2023, filed 15 May 2023.